Results 141 to 150 of about 3,564 (173)

Cystic Fibrosis and CFTR Modulators: The Impact on Bone Density, Muscle Mass and Strength in Children and Young Adolescents. [PDF]

Children (Basel)
Iordanidou K, Karakousis ND, Hatziagorou E, Chrysochoou EA, Galogavrou M, Sopiadou A, Papagianni M.   +6 more
europepmc   +1 more source

Assessment of efficacy and tolerability of elexacaftor-tezacaftor-ivacaftor in an observational cohort study of "aged" people with cystic fibrosis. [PDF]

Ther Adv Respir Dis
Blankenship S, Flueckiger BV, Caleb G, Bailey J, Baker E, Garcia B, Krick S.   +6 more
europepmc   +1 more source

Respiratory Oscillometry and Multimodal Lung Function Assessment of Elexacaftor/Tezacaftor/Ivacaftor Response in Children and Young Adults With Cystic Fibrosis. [PDF]

Pediatr Pulmonol
Kogias C, Sopiadou A, Fouzas S, Vantsi P, Chrysochoou EA, Desli E, Galogavrou M, Gasparis N, Hatziagorou E.   +8 more
europepmc   +1 more source

Impact of Cystic Fibrosis Transmembrane Conductance Regulator Modulating Therapies on Liver Transplant Outcomes. [PDF]

Gastro Hep Adv
Naimimohasses S, Ray A, Tan E, Wiggins A, Hasjim BJ, Chen S, Bhat M.   +6 more
europepmc   +1 more source

VX-659–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles [PDF]

New England Journal of Medicine, 2018
BACKGROUND The next-generation cystic fibrosis transmembrane conductance regulator (CFTR) corrector VX-659, in triple combination with tezacaftor and ivacaftor (VX-659–tezacaftor–ivacaftor), was developed to restore the function of Phe508del CFTR protein
Jane C Davies, Samuel M Moskowitz, Cynthia Brown   +2 more
exaly   +6 more sources

Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del [PDF]

New England Journal of Medicine, 2017
Background Combination treatment with the cystic fibrosis transmembrane conductance regulator (CFTR) modulators tezacaftor (VX-661) and ivacaftor (VX-770) was designed to target the underlying cause of disease in patients with cystic fibrosis.Methods In ...
Jennifer L Taylor-Cousar, Anne Munck, Edward F Mckone   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Elexacaftor/ivacaftor/tezacaftor

Reactions Weekly, 2022
  +7 more sources

Elexacaftor/ivacaftor/tezacaftor

Reactions Weekly, 2021
  +5 more sources

Elexacaftor/ivacaftor/tezacaftor/ivacaftor/tezacaftor

Reactions Weekly, 2021
openaire   +1 more source